Secondary carnitine deficiency is the more common condition resulting in low-levels of carnitine in healthy adults
Watch-outs to know: Anecdotal reports from those who use unregulated MOTS-c peptides include side effects such as heart palpitations, insomnia, fever, and general injection-site reactions
Practical guidance for patients Share your full medical history, including liver or kidney conditions, with your prescriber
The GO@GSH-FA treatment led to a significant downregulation of pro-apoptotic markers Bax and Caspase-3, while upregulating the anti-apoptotic protein Bcl-2
Liposomal encapsulation protects the molecule from GGT degradation
Unfortunately, unless we reverse these stressors or, at least, minimize them, the body will not produce enough Glutathione to help ward off the consequences